Search Results - "Balogh, Dora"

Refine Results
  1. 1

    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes by Hodrea, Judit, Saeed, Adar, Molnar, Agnes, Fintha, Attila, Barczi, Adrienn, Wagner, Laszlo J, Szabo, Attila J, Fekete, Andrea, Balogh, Dora B

    Published in PloS one (17-02-2022)
    “…Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cryo-EM structure of the ClpXP protein degradation machinery by Gatsogiannis, Christos, Balogh, Dora, Merino, Felipe, Sieber, Stephan A., Raunser, Stefan

    Published in Nature structural & molecular biology (01-10-2019)
    “…The ClpXP machinery is a two-component protease complex that performs targeted protein degradation in bacteria and mitochondria. The complex consists of the…”
    Get full text
    Journal Article
  4. 4

    10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease by BALOGH, DORA B., LENART, LILLA, HOSSZU, ADAM, SAEED, ADAR, HODREA, JUDIT, TOTH, AKOS R., SZABO, ATTILA J., FEKETE, ANDREA

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Introduction and aims: Diabetic kidney disease (DKD) is a major health concern among diabetic patients. Current therapies cannot halt the progression of renal…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Analysis of Telomerase by the Telomeric Hemin/G-Quadruplex-Controlled Aggregation of Au Nanoparticles in the Presence of Cysteine by Sharon, Etery, Golub, Eyal, Niazov-Elkan, Angelica, Balogh, Dora, Willner, Itamar

    Published in Analytical chemistry (Washington) (18-03-2014)
    “…Telomeres are guanosine-rich nucleic-acid chains that fold, in the presence of K+ ions and hemin, into the telomeric hemin/G-quadruplex structure, exhibiting…”
    Get full text
    Journal Article
  7. 7

    Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model by Balogh, Dora B, Molnar, Agnes, Degi, Arianna, Toth, Akos, Lenart, Lilla, Saeed, Adar, Barczi, Adrienn, Szabo, Attila J, Wagner, Laszlo J, Reusz, Gyorgy, Fekete, Andrea

    “…Diabetic cardiovascular complications are associated with up to 50% mortality, and current therapies are not effective enough. Renin-angiotensin-aldosterone…”
    Get full text
    Journal Article
  8. 8

    Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition by Balogh, Dora B., Molnar, Agnes, Hosszu, Adam, Lakat, Tamas, Hodrea, Judit, Szabo, Attila J., Lenart, Lilla, Fekete, Andrea

    Published in Psychoneuroendocrinology (01-08-2020)
    “…Summary of the antidepressant-like mechanism of RAAS-acting drugs. Systemic and local brain renin-angiotensin-aldosterone system (RAAS) are overactivated in…”
    Get full text
    Journal Article
  9. 9

    σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury by Hosszu, Adam, Antal, Zsuzsanna, Lenart, Lilla, Hodrea, Judit, Koszegi, Sandor, Balogh, Dora B, Banki, Nora F, Wagner, Laszlo, Denes, Adam, Hamar, Peter, Degrell, Peter, Vannay, Adam, Szabo, Attila J, Fekete, Andrea

    “…Mechanisms of renal ischemia-reperfusion injury remain unresolved, and effective therapies are lacking. We previously showed that dehydroepiandrosterone…”
    Get full text
    Journal Article
  10. 10

    Tailored Peptide Phenyl Esters Block ClpXP Proteolysis by an Unusual Breakdown into a Heptamer–Hexamer Assembly by Lakemeyer, Markus, Bertosin, Eva, Möller, Friederike, Balogh, Dóra, Strasser, Ralf, Dietz, Hendrik, Sieber, Stephan A.

    Published in Angewandte Chemie International Edition (20-05-2019)
    “…The proteolytic complex ClpXP is fundamental to bacterial homeostasis and pathogenesis. Because of its conformational flexibility, the development of potent…”
    Get full text
    Journal Article
  11. 11

    Selective Activation of Human Caseinolytic Protease P (ClpP) by Stahl, Matthias, Korotkov, Vadim S., Balogh, Dóra, Kick, Leonhard M., Gersch, Malte, Pahl, Axel, Kielkowski, Pavel, Richter, Klaus, Schneider, Sabine, Sieber, Stephan A.

    Published in Angewandte Chemie International Edition (26-10-2018)
    “…Caseinolytic protease P (ClpP) is the proteolytic component of the ClpXP protein degradation complex. Eukaryotic ClpP was recently found to act within the…”
    Get full text
    Journal Article
  12. 12

    Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling by Lenart, Lilla, Balogh, Dora B., Lenart, Nikolett, Barczi, Adrienn, Hosszu, Adam, Farkas, Tamas, Hodrea, Judit, Szabo, Attila J., Szigeti, Krisztian, Denes, Adam, Fekete, Andrea

    Published in Diabetologia (01-08-2019)
    “…Aims/hypothesis Diabetes is a worldwide epidemic linked with diverse diseases of the nervous system, including depression. A few studies suggested a connection…”
    Get full text
    Journal Article
  13. 13

    Insights into ClpXP proteolysis: heterooligomerization and partial deactivation enhance chaperone affinity and substrate turnover in Listeria monocytogenes by Balogh, Dóra, Dahmen, Maria, Stahl, Matthias, Poreba, Marcin, Gersch, Malte, Drag, Marcin, Sieber, Stephan A

    Published in Chemical science (Cambridge) (2017)
    “…Caseinolytic proteases (ClpP) are important for recognition and controlled degradation of damaged proteins. While the majority of bacterial organisms utilize…”
    Get full text
    Journal Article
  14. 14

    25-LB: SGLT2 Inhibitors Are Renoprotective via Mitigation of Tubular Hypoxia and Protein O-GlcNAcylation by BALOGH, DORA B., HODREA, JUDIT, LENART, LILLA, HOSSZU, ADAM, MEZEI, CSENGE, WAGNER, LASZLO, SZABO, ATTILA J., FEKETE, ANDREA

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Tubular hypoxia has a major pathogenic role in diabetic kidney disease (DKD). Hypoxia is in strong association with elevated glucose reabsorption and increased…”
    Get full text
    Journal Article
  15. 15

    Listeria monocytogenes utilizes the ClpP1/2 proteolytic machinery for fine-tuned substrate degradation at elevated temperatures by Balogh, Dóra, Eckel, Konstantin, Fetzer, Christian, Sieber, Stephan A.

    Published in RSC chemical biology (06-07-2022)
    “…Listeria monocytogenes exhibits two ClpP isoforms (ClpP1/ClpP2) which assemble into a heterooligomeric complex with enhanced proteolytic activity. Herein, we…”
    Get full text
    Journal Article
  16. 16

    An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis by Balogh, Dora Bianka, Wagner, Laszlo Jozsef, Fekete, Andrea

    “…Metabolic diseases, particularly diabetes mellitus (DM), are significant global public health concerns. Despite the widespread use of standard-of-care…”
    Get full text
    Journal Article
  17. 17

    Non-covalently embedded oxytocin in alkanethiol monolayer as Zn2+ selective biosensor by Attia, Jessica, Nir, Sivan, Mervinetsky, Evgeniy, Balogh, Dora, Gitlin-Domagalska, Agata, Alshanski, Israel, Reches, Meital, Hurevich, Mattan, Yitzchaik, Shlomo

    Published in Scientific reports (29-03-2021)
    “…Peptides are commonly used as biosensors for analytes such as metal ions as they have natural binding preferences. In our previous peptide-based impedimetric…”
    Get full text
    Journal Article
  18. 18
  19. 19

    RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition by Koszegi, Sandor, Molnar, Agnes, Lenart, Lilla, Hodrea, Judit, Balogh, Dora Bianka, Lakat, Tamas, Szkibinszkij, Edgar, Hosszu, Adam, Sparding, Nadja, Genovese, Federica, Wagner, Laszlo, Vannay, Adam, Szabo, Attila J, Fekete, Andrea

    Published in The Journal of physiology (01-01-2019)
    “…Key points Increased activation of the renin‐angiotensin‐aldosterone system (RAAS) and elevated growth factor production are of crucial importance in the…”
    Get full text
    Journal Article
  20. 20